Key result
Low-dose captopril plus losartan produces a synergistic, greater SBP reduction than either monotherapy.
Why the study?
The dose-dependent interaction effects of ACE inhibitors and AT1 blockers on blood pressure in SHR were not fully characterized.
RCT (n=6)
Randomized order
Answers are grounded in this paper and cite their sources.
May support additive BP effects of submaximal captopril-losartan combos in SHR models; leaves open human translation and practice change.
This study examined in SHR's the effect of a range of doses of captopril and losartan individually and in combination on BP studied by telemetry. Telemeters were inserted in 6 SHR's (Wt 200g) and allowed to recover for 2 weeks. The fall in BP 3-4h post dose to single doses of captopril 1.25, 2.5, 5, 10, 20, 40 mg/Kg and to losartan 1.25, 2.5, 5, 10, 20, 40 mg/Kg given intraperitoneally, and to the combination of the same doses were studied in a randomized order. When submaximal doses of each drug were used the effect of adding the other drug was synergistic and greater than doubling the dose of the individual agents. When doses with a plateau effect were used there was a small increment in response but this was less than additive. Combination of low doses of ACE inhibitors and AT1 blockers give a marked increase in effect. There is only a small additional effect when maximum doses of each drug are combined. (See Table) Fall in SBP mmHg p < 0.01 compared with either monotherapy
No takes yet. Share an insight, caveat, or question.
Trefor Owen Morgan (2002) conducted an RCT in Hypertension (n=6). Captopril and losartan combination vs. Captopril alone and losartan alone was evaluated on Fall in systolic blood pressure (SBP) (p=< 0.01). The combination of low doses of captopril and losartan produced a synergistic and greater fall in systolic blood pressure compared with either monotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: